insights_auto
Why is GMAB down 2.26%?
Dive Deeperchevron_right
GMAB:NASDAQ
Genmab A/S - ADR
$35.82
arrow_downward
-2.26%(-0.83) 1D
Oct 8, 1:31:50 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GMAB...
Open
$36.18
High
$36.21
Low
$35.09
Mkt. cap
22.02B
Avg. vol.
3.07M
Volume
2.28M
P/E ratio
28.19
52-wk high
$40.17
52-wk low
$23.62
EPS
$1.27
Beta
0.81
Shares outstanding
624.06M
No. of employees
3K
Open
$36.18
High
$36.21
Low
$35.09
Mkt. cap
22.02B
Avg. vol.
3.07M
Volume
2.28M
P/E ratio
28.19
52-wk high
$40.17
52-wk low
$23.62
EPS
$1.27
Beta
0.81
Shares outstanding
624.06M
No. of employees
3K
News stories
From web sources and news partners
Stock Titan
·
1 day ago
Awarded cost-free, Genmab (GMAB)'s 5,300 board stock units vest after three years.
Seeking Alpha
·
1 day ago
Genmab: Epkinly Shines In Phase 3 DLBCL Trial (NASDAQ:GMAB)
Zacks
·
2 days ago
AbbVie's Epcoritamab Combo Shows PFS Benefit in Frontline DLBCL
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab A/S - ADR
CEOJan G. J. van de Winkel
Employees3.12K
FoundedJun 11, 1998
Headquarters-
SectorBiotechnology
Websitegenmab.com